ABVC BioPharma, Inc. Operating Lease, Payments
ABVC BioPharma, Inc. (ABVC) reported Operating Lease, Payments of $20.10 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-12
- ABVC BioPharma, Inc. operating lease, payments for the quarter ending 2026-06-30 was $20.10K, a 42.44% decline year-over-year.
- ABVC BioPharma, Inc. operating lease, payments for the quarter ending 2026-03-31 was $38.85K, a 66.85% decline year-over-year.
- ABVC BioPharma, Inc. operating lease, payments for the quarter ending 2025-12-31 was $28.91K.
- ABVC BioPharma, Inc. operating lease, payments for the quarter ending 2025-09-30 was $19.32K.
- ABVC BioPharma, Inc. operating lease, payments for fiscal 2025 was $102.76K, a 55.01% decline from fiscal 2024.
- ABVC BioPharma, Inc. operating lease, payments for fiscal 2024 was $228.39K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 21 month |
|---|---|---|---|---|---|
| 2026-06-30 | $20.10K 10-Q · filed 2026-08-12 | $58.95K 10-Q · filed 2026-08-12 | $87.85K derived: sum of 3 quarters · filed 2026-08-12 | $107.17K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $38.85K 10-Q · filed 2026-05-18 | $67.75K derived: sum of 2 quarters · filed 2026-05-18 | $87.07K derived: sum of 3 quarters · filed 2026-05-18 | $121.99K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $28.91K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $48.22K derived: sum of 2 quarters · filed 2026-03-03 | $83.14K derived: sum of 3 quarters · filed 2026-08-12 | $102.76K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $19.32K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $54.23K derived: sum of 2 quarters · filed 2026-08-12 | $73.86K 10-Q/A · filed 2026-03-03 | $199.19K 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $34.92K 10-Q · filed 2026-08-12 | $54.54K 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | $117.17K 10-Q · filed 2026-05-18 | ||||
| 2024-12-31 | $228.39K 10-K · filed 2026-03-03 | ||||
| 2024-06-30 | $100.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $199.19K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $98.50K 10-Q · filed 2025-04-30 |